Andere talen Aileron Therapeutics, Inc.

Aandelen

ALRN

US00887A2042

Beurs gesloten - Nasdaq Andere beurzen 22:30:00 25-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
5 ^USD	+1,42%		0,00%	+64,01%

18/04	AILERON THERAPEUTICS, INC. : Ladenburg Thalmann geeft koopadvies	ZM
15/04	Aileron Therapeutics, Inc. rapporteert winstresultaten voor het volledige jaar dat eindigde op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Aileron Therapeutics : Corporate Presentation April 2024	15/04
Aileron Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	15/04
Aileron Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	15/04
Aileron Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	15/04
Aileron Therapeutics : Management Change/Compensation - Form 8-K	29/03
Aileron Therapeutics, Inc. Announces CFO Changes	29/03
Aileron Therapeutics, Inc. Announces Board Changes	29/03
Aileron Therapeutics Names Brian Windsor as CEO	12/03
Aileron Therapeutics Announces CEO Transition	12/03
Aileron Therapeutics, Inc. Announces Appointment of Brian Windsor as President and to the Board of Directors	12/03
Aileron Therapeutics, Inc. Announces CEO Changes	12/03
Aileron Therapeutics, Inc. Announces Resignation of Nolan Sigal, M.D., Ph.D. from Board of Directors, Member of Nominating and Corporate Governance Committee	01/03
Aileron Therapeutics and Pulmonary Care Experts To Discuss the Potential Implications of LTI-03 for Idiopathic Pulmonary Fibrosis in Virtual Key Opinion Leader Event	15/02
Aileron Therapeutics to Host Key Opinion Leader Event on February 15, 2024	01/02
North American Morning Briefing : Stock Futures, -2-	04/12
Aileron Therapeutics Acquires Lung Therapeutics in Stock-for-Stock Deal	31-10-23
Aileron Therapeutics : Merger Announcement	31-10-23
Aileron Therapeutics Announces Acquisition of Lung Therapeutics	31-10-23
Aileron Therapeutics, Inc. acquired Lung Therapeutics, Inc.	31-10-23
Aileron Therapeutics, Inc. announced that it expects to receive $16.4 million in funding from Nantahala Capital Management, LLC and other investors	31-10-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Aileron Therapeutics, Inc.

Aandelen

ALRN

US00887A2042

Andere talen

Filters